Phase I, double-blind, randomized, placebo-controlled clinical trial with the probiotic Nyaditum resae® in adults with or without latent tuberculosis infection

Category Primary study
JournalClinical Therapeutics
Year 2015
This article has no abstract
Epistemonikos ID: 044ec2b60c18c9cfb563085948a88fb5f32e43d3
First added on: Feb 07, 2025